Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
A Phase I Study of DS-3201B in Subjects With Acute Myelogenous Leukemia (AML) Or Acute Lymphocytic Leukemia (ALL)
Administered By
Duke Cancer Institute
Awarded By
Daiichi Sankyo Inc
Contributors
Erba, Harry Paul
Principal Investigator
Start/End
September 19, 2018 - February 24, 2024